ELOVL2 and benign prostatic hyperplasia: ELOVL2 exhibited the most pronounced upregulation in both PCa tissues (Figure 1B) and PCa cell lines compared to the benign prostatic hyperplasia (BPH) cell line BPH-1(Figure 1C; Supplementary Figure S1).